|
Blezinger, P., Wang, J., Gondo, M., Quezada, A., Mehrens, D., French, M., Singhal, A., Sullivan, S., Rolland, A., Ralston, R., and Min, W. (1999) Systemic inhibition of tumor growth and tumor metastases by intramuscular administration of the endostatin gene. Nature Biotechnology 17, 343-348. Boehm, T., Folkman, J., Browder, T., and O'Reilly, M.S. (1997) Antiangiogenic therapy of experimental cancer does not induce acquired drug resistance. Nature 390, 404-407. Brooks, P.C., Silletti, S., Schalscha, T.L.V., Friedlander, M., and Cheresh, D.A. (1998) Disruption of angiogenesis by PEX, a noncatalytic metalloproteinase fragment with integrin binding activity. Cell 92, 391-400. Cao, Y., Ji, R.W., Davidson, D., Schaller, J., Marti, D., Sohndel, S., McCance, S.G., O'reilly, M.S., Llinas, M., and Folkman, J. (1996) Kringle domains of human angiostatin. J. Biol. Chem. 271, 29461-29467. Cao, Y., Chen, A., An, S.S.A., Ji, R.W., Davidson, D., Cao, Y., and Llinas, M. (1997) Kringle 5 of plasminnogen is a novel inhibitor of endothelial cell growth. J. Biol. Chem. 272, 22924-22928. Cao, Y., O'reilly, M.S., Marshall, B., Flynn, E., Ji, R.W., and Folkman, J. (1998) Expression of angiostatin cDNA in a murine fibrosarcoma suppresses primary tumor growth and produces long-term dormacy of metastases. J. Clin. Invest. 101, 1055-1063. Chen, B.F., Hwang, L.H., and Chen, D.S. (1993) Characterization of a bicistronic retroviral vector composed of the swine vesicular disease virus internal ribosome entry site. J. Viol. 67, 2142-2148. Chomczynski, P., and Sacchi, N. (1987) Single-step method of RNA isolation by acid quanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162, 156-159. Chow, N.H., Hsu, P., Lin, X.Z., Yang, H.B., Chan, S.H., Cheng, K.S., Huang, S.M., and Su, I.J. (1997) Expression of vascular endothelial growth factor in normal liver and hepatocellular carcinoma. Human Pathology 28, 698-703. Claesson-Welsh, L., Welsh, M., Ito, N., Anand-Apte, B., Soker, S., Zetter, B., O'Reilly, M., and Folkman, J. (1998) Angiostatin induces endothelial cell apoptosis and activation of focal adhesion kinase independently of the integrin-binding motif RGD. Proc. Natl. Acad. Sci. USA 95, 5579-5583. Clark, W.H., Jr., Elder, D.E., Guerry, D.I., Braitman, L.E., Trock, B.J., Schultz, D., Synnestevdt, M., and Halpern, A.C. (1989) Model predicting survival in stage I melanoma based on tumor progression. J. Natl. Cancer Inst. 81, 1893-1904. Dhanabal, M., Ramchandran, R., Volk, R., Stillman, I.E., Lombardo, M., Iruela-Arispe, M.L., Simons, S., and Sukhatme, V.P. (1999) Endostatin:Yeast production, mutants, and anti-tumor effect in renal cell carcinoma. Cancer Res. 59, 189-197. Dong, Z., Jumar, R., Yang, X., and Fidler, I.J. (1997) Macrophage-derived metalloelastase is responsible for the generation of angiostatin in Lewis lung carcinoma. Cell 88, 801-810. Fidler I.J. (1991) Cancer metastasis. British Medical Bulletin 47, 157-177. Fidler, I.J., and Ellis, L.M. (1994) The implication of angiogenesis for the biology and therapy of cancer metastasis. Cell 79, 185-188. Folkman J. (1971) Tumor angiogenesis:therapeutic implications. New Engl. J. Med. 285, 1182-1186. Folkman, J. (1986) How is blood vessel growth regulated in normal and neoplastic tissue? Cancer Res. 46, 467-473. Folkman, J., and Klagsbrun, M. (1987) Angiogenic factors. Science 235, 442-447. Folkman, J. (1990) What is the evidence that tumors are angio-genesis dependent? J. Natl. Cancer Inst. 82, 4-6. Folkman, J., and Shing, Y. (1992) Angiogenesis. J. Biol. Chem. 267, 10931-10934. Folkman, J. (1996a) Fighting cancer by attacking its blood supply. Scientific American 275, 150-154. Folkman, J. (1996b) Tumor angiogenesis and tissue factor. Nature Medicine 2, 167-168. Fong T.A.T., Shawver, L.K., Sun, L., Tang, C., App, H., Powell, T.J., Kim, Y.H., Schreck, R., Wang, X., Risau, W., Ullrich, A., Hirth, K.P., and McMahon, G. (1999) SU5416 is a potent and selective inhibitor of the vascular endothelial growth factor receptor(Flk-1/KDR) that inhibits tyrosine kinase catalysis, tumor vascularization, and growth of multiple tumor types. Cancer Res. 59, 99-106. Forsgren, M., Raden, B., Israelsson, M., Laesson, K., and Heden, L.O. (1987) Molecular cloning and characterization of a full-length cDNA for human plasminogen. FEBS Lett. 213, 254-260. Gately, S., Twardowski, P., Stack, M.S., Patrick, M., Boggio, L., Cundiff, D.L., Schnaper, H.W., Madison, L., Volpert, O., Bouck, N., Enghild, J., Kwaan, H.C., and Soff, G.A. (1996) Human prostata carcinoma cells express enzymatic activity that converts human plasminogen to angiogenesis inhibitor, angiostatin. Cancer Research 58, 4887-4890. Gately, S., Twardowski, P., Stack, M.S., Cundiff, D.L., Grella, D., Castellino, F.J., Enghild, J., Keaan, H.C., Lee, F., Kramer, R.A., Volpert, O., Bouck, N., and Soff, G.A. (1997) The mechanism of cancer-mediated conversion of plasminogen to the angiogensis inhibitor angiostatin. Proc. Natl. Acad. Sci. USA 94, 10868-10872. Graham, F.L., and Smiley, J. (1977) Characteristics of a human cell line transformed by DNA from human adenovirus type 5. J. Gen. Virol. 36, 59-72. Griscelli, F., Li, H., Bennaceur-Griscelli, A., Soria, J., Opolon, P., Soria, C., Perricaudet, M., Yeh, P., and Lu, H. (1998) Angiostatin gene transfer:inhibition of tumor growth in vivo by blockage of endothelial cell proliferation associated with a mitosis arrest. Proc. Natl. Acad. Sci. USA 95, 6367-6372. Hanahan, D., and Folkman, J. (1996) Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell 86, 353-364. Hanahan, D. (1997) Signaling vascular morphogenesis and maintenance. Science 277, 48-50. Hanahan, D. (1998) A flanking attack on cancer. Nature Medicine 4, 13-14. He, T.-C., Zhou, S., Costa, L.T.D., Yu, J., Kinziler, K.W., and Vogelstein, B. (1998) A simplified system for generating recombinant adenoviruses. Proc. Natl. Acad. Sci. USA 95, 2509-2514. Hobson, B., and Denekamp, J. (1984) Endothelial proliferation in tumor and normal tissues:continuous labelling studies. Br. J. Cancer 49, 405-413. Holmgren, L., O'Reilly, M.S., and Folkman, J. (1995) Dormancy of micrometastases:balanced proliferation and apoptosis in the presence of angiogenesis suppression. Nature Med. 1, 149-153. Hori, A., Sasada, R., Matsutani, E., Naito, K., Sakura, Y., Fujita, T., and Kozai, Y. (1991) Suppression of solid tumor growth by immononeutralizing monoclonal antibody against human basic fibroblast growth factor. Cancer Res. 51, 6180-6184. Hsieh, C.L., Chen, B.F., Wang, C.C., Liu, H.H., Chen, D.S., and Hwang, L.H. (1995) Improved gene expression by a modified bicistronic retroviral vector. Biochemical and Biophysical Research Communications 214, 910-917. Kim, K.J., Li, B., Winer, J., Armanini, M., Gillett, N., Phillips, H.S. et al. (1993) Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumor growth in vivo. Nature 362, 841-844. Klagsbrun, M. (1999) Angiogenesis and cancer. Cancer Res. 59, 487-490. Kong, H.L., Hecht, D., Song, W., Kovesdi, I., Hackett, N.R., Yayon, A., and Crystal, R.G. (1998) Regional suppression of tumor growth by in vivo transfer of a cDNA encoding a secreted form of the extracellular domain of the flt-1 vascular endothelial growth factor receptor. Human Gene Therapy 9, 823-833. Maisonpierre, P.C., Suri, C., Jones, P.F., Bartunkova, S., Wiegand, S.J., Radziejewski, C., Compton, D., McClain, J., Aldrich, T.H., Papadopoulos, N., Daly, T.J., Davis, S., Sato, T.N., and Yancopoulos, G.D. (1997) Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis. Science 277, 55-60. Markowitz, D., Goff, S., and Bank, A. (1988) A safe packaging line for gene transfer:separating viral genes on the different plasmids. J. Virol. 62, 1120-1124. Mauceri, H.J., Hanna, N.N., Beckett, M.A., Gorski, D.H., Staba, M.J., Stellato, K.A., Bigelow, K., Heimann, R., Gately, S., Dhanabal, M., Soff, G.A., Sukhatme, V.P., Kufe, D.W., and Weichselbaum, R.R. (1998) Combined effects of angiostatin and ionizing radiation in antitumour therapy. Nature 394, 287-290. Mise, M., Arii, S., Higashituji, H., Furutani, M., Niwano, M., Harada, T., Ishigami, S., Toda, Y., Nakayama, H., Fukumoto, M., Fujita, J., and Imamura, M. (1996) Clinical significance of vascular endothelial growth factor and basic fibroblast growth factor gene expression in liver tumor. Hepatology 23, 455-464. Moser, T.L., Stack, M.S., Asplin, I., Enghild, J.J., Hojrup, P., Everitt, L., Hubchak, S., Schnaper, H.W., and Pizzo, S.V. (1999) Angiostatin binds ATP synthase on the surface of human endothelial cells. Proc. Natl. Acad. Sci. USA 96, 2811-2816. Nguyen, J.T., Wu, P., Clouse, M.E., Hlatky, L., and Terwilliger, E.F.(1998) Adeno-associated virus-mediated delivery of antiangiogenic factors as an antitumor strategy. Cancer research 58, 5673-5677. Obeso, J., Weber, J., and Auerbach, R. (1990) A hemangio-endothelioma-derived cell line:its use as a model for study of endothelial cell biology. Lab.Invest. 63, 259-269. Oh, S.P., Warman, M.L., Seldin, M.F., Cheng, S.D., Knoll, J.H.M.,Timmons, S., Olsen, B.R. (1994) Cloning of cDNA and genomic DNA encoding human type XVIII collagen and locali-zation of the a1(XVIII) collagen gene to mouse chromosome 10 and human chromosome 21. Genomics 19, 494-499. O'reilly, M.S., Holmgren, L., Shing, Y., Chen, C., Rosenthal, R.A., Moses, M., Lane, W.S., Cao, Y., Sage, E.H., and Folkman, J. (1994) Angiostatin : a novel angiogenesis inhibitor that mediates the suppression of metastases by a lewis lung carcinoma. Cell 79, 315-328. O'reilly, M., Rosenthal, R., Sage, E.H., Smith, S., Holmgren, L., Moses, M., Shing, Y., and Folkman, J. (1993) The suppression of tumor metastases by a primary tumar. Surg. Forum. 44, 474-476. O'reilly, M.S., Holmgren, L., Chen, C., and Folkman, J. (1996) Angiostatin induces and sustains dormancy of human primary tumors in mice. Nature Medicine 2, 689-692. O'Reilly, M.S., Boehm, T., Shing, Y., Fukai, N., Vasios, G., Lane, W.S., Flynn, E., Birkhead, J.R., Olsen, B.R., and Folkman, J. (1997) Endostatin:an endogenous inhibitor of angiogenesis and tumor growth. Cell 88, 277-285. Pluda, J.M. (1997) Tumor-associated angiogenesis:mechanism, clinical implication, and therapeutic strategies. Seminars in Oncology 24, 203-218. Pluda, J.M., and Parkinson, D.R. (1996) Clinical implications of tumor-associated neovascularization and current antiangio-genic strategies for the treatment of malignancies of pancreas. Cancer Supplement 78, 680-687. Poste, G., and Fidler, I.J. (1980) The pathogenesis of cancer metastasis. Nature 283, 139-145. Rak, J., Filmus, J., Finkenzeller, G., Grugel, S., Marme, D., and Kerbel, R.S. (1995) Oncogene as inducer of tumor angiogenesis. Cancer and Metastasis Reviews 14, 263-277. Relf, M., LeJeune, S., Scott, P.A.E., Fox, S., Smith, K., Leek, R., Moghaddam, A., Whitehouse, R., Bicknell, R., and Harris, A.L. (1997) Expression of the angiogenic factors vascular endothelial cell growth factor, acidic and basic fibroblast growth factor, tumor growth factor b-1, platelet-derived endothelial cell growth factor, placenta growth factor, and pleiotrophin in human primary breast cancer and its relation to angiogenesis. Cancer Res. 57, 963-969. Risau, W. (1997) Mechanisms of angiogenesis. Nature 386, 671-674. Shalaby, F. et al. (1995) Failure of blood-island formation and vasculogenesis in flk-1-deficient mice. Nature 376, 62-66. Sim, B.K.L., O'Reilly, M.S., Liang, H., Fortier, A.H., He, W., Madsen, J.W., Lapcevich, R., and Nacy, C.A. (1997) A recombinant human angiostatin protein inhibits experimental primary and metastatic cancer. Cancer Res. 57, 1329-1334. Stathakis, P., Fitzgerald, M., Matthias, L.J., Chesterman, C.N., and Hogg, P.J. (1997) Generation of angiostatin by reduction and proteolysis of plasmin. J. Biol. Chem. 272, 20641-20645. Tanaka, T., Manome, Y., Wen, P., Kufe, D.W., Fine, H.A. (1997) Viral vector-mediated transduction of a modified platelet factor 4 cDNA inhibits angiogenesis and tumor growth. Nature Med. 3, 437-442. Tanaka, T., Cao, Y., Folkman, J., and Fine, H.A. (1998) Viral vector-targeted antiangiogenic gene therapy utilizing an angiostatin complementary DNA. Cancer Res. 58, 3362-3369. Voest, E.E., Kenyon, B.M., O'Reilly, M.S., Truitt, G., D'Amato, R.J., and Folkman, J. (1995) Inhibition of angiogenesis in vivo by interleukin 12. J. Natl. Cancer Inst. 87, 581-586. Wu, Z., O'Reilly, M.S., Folkman, J., and Shing, Y. (1997) Suppression of tumor growth with recombinant murine angiostatin. Biochem. Biophys. Res. Commun. 236, 651-654. Yancopoulos, G., Klagsbrun, M., and Folkman, J. (1998) Vasculogenesis, angiogenesis, and growth factors:ephrins enter the fray at the border. Cell 93, 661-664. Yeh, C.H., Peng, H.C., and Huang, T.F. (1998) Accutin, a new disintegrin, inhibits angiogenesis in vitro and in vivo by acting as integrin aVb3 antagonist and inducing apoptosis. Blood 92, 3268-3276.
|